Semler Scientific Inc Asset Turnover Ratio (SMLR), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Semler Scientific inc   (NASDAQ: SMLR)
 

Semler Scientific Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the third quarter 2025, Semler Scientific Inc 's asset turnover ratio sequentially decreased to 0.09 in the third quarter (Sep 30 2025), this is lower than usual.

Within sector 58 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2025, to 1666, from total ranking in the second quarter 2025 at 2053.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SMLR Asset Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change 562.2 % 534.55 % 274.22 % 231.51 % 22.96 %
Y / Y Revenue Change -44.56 % -43.19 % -44.44 % -17.55 % -17.19 %
Asset Turnover Ratio (TTM) 0.09 0.15 0.28 0.46 0.73
SMLR's Total Ranking # 1666 # 2053 # 2529 # 2011 # 1164
Seq. Asset Change 14.27 % 82.4 % 19.05 % 166.87 % 9.49 %
Seq. Revenue Change -8.84 % -6.99 % -28.83 % -8.13 % -6.59 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 59
Healthcare Sector # 182
Overall Market # 1666

Asset Turnover Ratio Statistics
High Average Low
17.5 10.63 4.93
(Dec 31 2020)   (Mar 31 2025)




SMLR Company Profile • Back to SMLR Efficiency Comparisons • Compare SMLR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Gossamer Bio Inc   0.17 $ 44.051  Millions$ 261.407  Millions
60 Degrees Pharmaceuticals Inc   0.17 $ 0.944  Millions$ 5.652  Millions
Xencor Inc  0.17 $ 150.132  Millions$ 901.217  Millions
Pacific Biosciences Of California Inc   0.16 $ 154.272  Millions$ 937.466  Millions
Cervomed Inc   0.16 $ 6.160  Millions$ 37.588  Millions
Legend Biotech Corporation  0.16 $ 272.330  Millions$ 1,672.178  Millions
Arbutus Biopharma Corp  0.16 $ 14.606  Millions$ 89.765  Millions
Insmed Inc  0.16 $ 342.104  Millions$ 2,167.140  Millions
Maxcyte inc   0.15 $ 34.418  Millions$ 225.664  Millions
Cannapharmarx Inc   0.15 $ 1.706  Millions$ 11.290  Millions
Femasys Inc   0.15 $ 2.062  Millions$ 13.948  Millions
Kura Oncology Inc   0.15 $ 104.029  Millions$ 708.932  Millions
Ginkgo Bioworks Holdings Inc   0.14 $ 180.606  Millions$ 1,272.771  Millions
Inspiremd Inc   0.14 $ 6.938  Millions$ 49.323  Millions
Nurix Therapeutics Inc   0.14 $ 83.687  Millions$ 599.603  Millions
Skinvisible Inc   0.14 $ 0.020  Millions$ 0.146  Millions
Entrada Therapeutics Inc   0.13 $ 61.520  Millions$ 468.620  Millions
Beyond Air Inc   0.13 $ 4.795  Millions$ 36.526  Millions
Ocular Therapeutix Inc   0.13 $ 55.784  Millions$ 431.518  Millions
Royalty Pharma Plc  0.13 $ 2,349.844  Millions$ 18,375.313  Millions
Eyepoint Inc   0.13 $ 42.340  Millions$ 333.468  Millions
Kamada Ltd   0.13 $ 47.010  Millions$ 373.186  Millions
Meiragtx Holdings Plc  0.12 $ 27.417  Millions$ 220.488  Millions
Sintx Technologies Inc   0.12 $ 1.270  Millions$ 10.355  Millions
Igc Pharma Inc   0.12 $ 1.106  Millions$ 9.084  Millions
Silence Therapeutics Plc  0.12 $ 25.830  Millions$ 216.414  Millions
Lucid Diagnostics Inc   0.11 $ 4.399  Millions$ 38.845  Millions
Valion Bio Inc   0.11 $ 0.482  Millions$ 4.330  Millions
Metagenomi Therapeutics Inc   0.11 $ 30.913  Millions$ 285.672  Millions
Coya Therapeutics Inc   0.11 $ 3.988  Millions$ 37.062  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.